The Tasmanian devil's cancer

A week or so ago, Ann Maree Pearce, a government cytogeneticist from Australia's island state, Tasmania, and colleagues said in a Nature news report that a nasty facial cancer affecting the Tasmanian devil population, dubbed Devil Facial Tumour Disease, was in fact an infective cell line being passed between the ferocious, foxed-sized scavengers via bites and so on. At the linkurl:18th Lorne Cancer Conference Erskine on the Beach;http://www.the-scientist.com/blog/display/23110/ in Lorne, Austra

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A week or so ago, Ann Maree Pearce, a government cytogeneticist from Australia's island state, Tasmania, and colleagues said in a Nature news report that a nasty facial cancer affecting the Tasmanian devil population, dubbed Devil Facial Tumour Disease, was in fact an infective cell line being passed between the ferocious, foxed-sized scavengers via bites and so on. At the linkurl:18th Lorne Cancer Conference Erskine on the Beach;http://www.the-scientist.com/blog/display/23110/ in Lorne, Australia, Pearce explained how she had initially tried performing a chromosomal analysis of samples taken from numerous devils across the island in the hope of spotting a common breakpoint. She found to her surprise that they were identical in every case, regardless of whether the host animal was male or female. It was only when they came across Errol (named in honor of the famous Tasmanian actor Errol Flynn) a devil with a pericentric inversion on chromosome 5, that the penny dropped. The inverted 5 was not present in the facial growth, Pearce explained. 'So Errol's cancer had to come from someone else.' The tumour is fatal and spreading fast in the Tasmanian devil population, she said, thanks to their endless fighting and 'rough foreplay.' The hope is that a vaccine can be developed before the population dwindles any further.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Pincock

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours